A cross-over pharmacokinetic study of a double viral inactivated factor IX concentrate (15 nm filtration and SD) compared to a SD factor IX concentrate.
Goudemand, J
A cross-over pharmacokinetic study of a double viral inactivated factor IX concentrate (15 nm filtration and SD) compared to a SD factor IX concentrate. [electronic resource] - Thrombosis and haemostasis Dec 1998 - 919-24 p. digital
Publication Type: Clinical Trial; Comparative Study; Journal Article; Multicenter Study; Randomized Controlled Trial
0340-6245
Adolescent
Adult
Antithrombin III--analysis
Area Under Curve
Biomarkers
Child
Cross-Over Studies
Detergents
Double-Blind Method
Factor IX--isolation & purification
Filtration
Half-Life
Hemophilia B--blood
Humans
Male
Middle Aged
Peptide Fragments--analysis
Peptide Hydrolases--analysis
Prothrombin--analysis
Safety
Solvents
Treatment Outcome
Virus Diseases--prevention & control
A cross-over pharmacokinetic study of a double viral inactivated factor IX concentrate (15 nm filtration and SD) compared to a SD factor IX concentrate. [electronic resource] - Thrombosis and haemostasis Dec 1998 - 919-24 p. digital
Publication Type: Clinical Trial; Comparative Study; Journal Article; Multicenter Study; Randomized Controlled Trial
0340-6245
Adolescent
Adult
Antithrombin III--analysis
Area Under Curve
Biomarkers
Child
Cross-Over Studies
Detergents
Double-Blind Method
Factor IX--isolation & purification
Filtration
Half-Life
Hemophilia B--blood
Humans
Male
Middle Aged
Peptide Fragments--analysis
Peptide Hydrolases--analysis
Prothrombin--analysis
Safety
Solvents
Treatment Outcome
Virus Diseases--prevention & control